Screener
United Therapeutics UTHR Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's other non-current liabilities?
- United Therapeutics (UTHR) reported other non-current liabilities of $212M in Q2 2026.
- How has United Therapeutics's other non-current liabilities changed year-over-year?
- United Therapeutics's other non-current liabilities increased by 2.3% year-over-year, from $207.3M to $212M.
- What is the long-term trend for United Therapeutics's other non-current liabilities?
- Over 5 years (2020 to 2025), United Therapeutics's other non-current liabilities has grown at a 18.3% compound annual growth rate (CAGR), from $96.5M to $223.2M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about United Therapeutics's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude